IPO registrations (S-1, F-1) · Registrants
OTONOMY, INC.
- SEC CIK
- 1493566 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2014-07-11, last 2015-01-21; 2 initial registrations, 3 amendments
- Outcome
- Final prospectus filed 2014-08-13; declared effective 2014-08-12
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 4796 EXECUTIVE DRIVE, San Diego, CA 92121
- EIN
- 26-2590070
- EDGAR entity type
- operating
- Insiders and CEO pay
- OTONOMY, INC. on the corporate pages
Offering terms
- Proposed price range
- $14.00–$16.00 per share (S-1/A filed 2014-08-01)
- Final price
- $16.00 per share, within the range (424B4 filed 2014-08-13, an initial public offering)
- Shares sold
- 6,250,000
- Gross proceeds
- $100,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol OTIC
- Lead underwriters
- Merrill Lynch; J.P. Morgan
- Syndicate
- BofA Securities; Piper Sandler; Sanford C. Bernstein
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: OTONOMY, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: OTONOMY, Inc. Fuzzy (name and state)
- Business registration: OTONOMY INC. Fuzzy (name and state)
- Business registration: OTONOMY, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: OTONOMY, INC. EXACT (EIN (EXACT))
- Federal award recipient: OTONOMY, INC. Fuzzy (name and state)
- Lobbying client: OTONOMY CORPORATION Fuzzy (name and state)
- SEC filer: Otonomy, Inc. EXACT (CIK (EXACT))
Filings 11
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2014-07-11 | S-1 | S-1 (registration) | Otonomy, Inc. | 0001193125-14-266440 ↗ |
| 2014-07-28 | S-1/A | S-1/A (amendment) | Otonomy, Inc. | 0001193125-14-282490 ↗ |
| 2014-08-01 | S-1/A | S-1/A (amendment) | Otonomy, Inc. | 0001193125-14-290521 ↗ |
| 2014-08-12 | S-1MEF | S-1MEF (added securities) | Otonomy, Inc. | 0001193125-14-307120 ↗ |
| 2014-08-12 | EFFECT | EFFECT (declared effective) | Otonomy, Inc. | 9999999995-14-002477 ↗ |
| 2014-08-13 | 424B4 | 424B4 (final prospectus) | Otonomy, Inc. | 0001193125-14-308434 ↗ |
| 2015-01-08 | S-1 | S-1 (registration) | Otonomy, Inc. | 0001193125-15-005155 ↗ |
| 2015-01-21 | S-1/A | S-1/A (amendment) | Otonomy, Inc. | 0001193125-15-016198 ↗ |
| 2015-01-22 | EFFECT | EFFECT (declared effective) | Otonomy, Inc. | 9999999995-15-000179 ↗ |
| 2015-01-23 | 424B4 | 424B4 (final prospectus) | Otonomy, Inc. | 0001193125-15-018761 ↗ |
| 2015-09-14 | EFFECT | EFFECT (declared effective) | Otonomy, Inc. | 9999999995-15-002506 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-08-01 | S-1/A | registration statement | $14.00–$16.00 | $15.00 | 5,333,333 | $79,999,995 | Nasdaq OTIC | 5 | primary document; range, price sentence, shares headline, proceeds computed, cover names 4 | document ↗ |
| 2014-08-13 | 424B4 | final prospectus | $16.00 | 6,250,000 | $100,000,000 | Nasdaq OTIC | 5 | primary document; price sentence, shares headline, proceeds table, cover names 4 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Avalon Ventures VIII LP | TenPercentOwner | 2 | 2014 | ||
| Avalon Ventures X, L.P. | TenPercentOwner | 2 | 2014 | ||
| Bisgaard Peter | Director | 1 | 2014 | ||
| BLAIR JAMES C | TenPercentOwner | 4 | 2014 | ||
| BONDERMAN DAVID | TenPercentOwner | 2 | 2014 | ||
| CAPPS VICKIE L | Director | 12 | 2014–2022 | ||
| Cayer Paul E | Officer | CFO/Ch. Business Offcr & Sec.; Ch. Financial & Business Offcr; President and CFBO | 18 | 2014–2022 | |
| COULTER JAMES G | TenPercentOwner | 2 | 2014 | ||
| Domain Partners VIII, L.P. | TenPercentOwner | 3 | 2014 | ||
| DOVEY BRIAN H | Director; Director,TenPercentOwner | 5 | 2014–2015 | ||
| DP VIII Associates, L.P. | TenPercentOwner | 2 | 2014 | ||
| Halak Brian K | TenPercentOwner | 4 | 2014 | ||
| ISALY SAMUEL D | Director; TenPercentOwner | 5 | 2014–2015 | ||
| Khuong Chau Quang | Director; Director,TenPercentOwner | 7 | 2014–2016 | ||
| LeBel Carl | Officer | Chief Scientific Officer | 8 | 2014–2016 | |
| Lichter Jay | Director; Director,TenPercentOwner | 14 | 2014–2022 | ||
| MCKEARN JOHN P | Director | 2 | 2014 | ||
| Novo A/S | TenPercentOwnerOther | 3 | 2014 | ||
| ORBIMED ADVISORS LLC | Director; TenPercentOwner | 5 | 2014–2015 | ||
| OrbiMed Capital GP IV LLC | Director; TenPercentOwner | 5 | 2014–2015 | ||
| Preston Heather | Director | 6 | 2014–2019 | ||
| Savel Robert Michael II | Officer | Chief Technical Officer | 16 | 2014–2022 | |
| SCHOEMAKER KATHLEEN K | TenPercentOwner | 4 | 2014 | ||
| TPG Group Holdings (SBS) Advisors, Inc. | TenPercentOwner | 2 | 2014 | ||
| TREU JESSE I | TenPercentOwner | 4 | 2014 | ||
| VITULLO NICOLE | TenPercentOwner | 4 | 2014 | ||
| Weber David Allen | Director; Director,Officer | President & CEO | 21 | 2014–2022 | |
| Yost Anthony J | Officer | Chief Commercial Officer | 3 | 2014–2016 | |
| Hakanson Dean | Officer | Chief Medical Officer | 4 | 2015–2017 | |
| MORROW GEORGE J | Director | 4 | 2015–2017 | ||
| LOUMEAU ERIC J | Officer | GC & Chief Compliance Officer | 7 | 2015–2018 | |
| Schroeder Theodore R | Director | 9 | 2015–2022 | ||
| McGill Iain | Director | 8 | 2016–2022 | ||
| Bishop Katherine Mary | Officer | Chief Scientific Officer | 5 | 2017–2019 | |
| BREITMEYER JAMES B | Director | 6 | 2018–2022 | ||
| Kennedy Ciara | Director | 5 | 2020–2022 | ||
| Foster Alan Charles | Officer | Chief Scientific Officer | 3 | 2021–2022 | |
| Broadfoot Jill Marie | Director | 3 | 2021–2022 | ||
| HOGAN H MICHAEL III | Director | 1 | 2023 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.